Medical Marijuana, Inc. Subsidiary HempMeds® Applauds Mexico’s Chamber of Deputies for Approving Federal Marijuana Legalization
March 17, 2021 09:00 ET
| Source:
Medical Marijuana, Inc.
Medical Marijuana, Inc.
SAN DIEGO, CA, March 17, 2021 (GLOBE NEWSWIRE) -- via
NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® applauds Mexico’s Chamber of Deputies for approving a bill to federally legalize marijuana.
“At HempMeds Mexico, we have watched both regulations and public sentiment shift in favor of cannabis legalization over the years and see this recent legislation as one step closer to federal cannabis legalization in Mexico,” said HempMeds® CEO Raúl Elizalde. “With that said, we hope that legislators will analyze the over-regulation of hemp products in the next stages of the legislative process and focus on non-psychoactive cannabis derivatives without recreational or medical purposes, like cosmetics, food, and others.”